He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
read more
Co-Author
Kinjoll Dey
Senior Research Analyst
He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, clinical publications, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health, European Medicines Agency (EMA), Centers for Disease Control and Prevention (CDC) Division of Reproductive Health, World Health Organization (WHO) Department of Sexual and Reproductive Health and Research, American Society for Reproductive Medicine (ASRM), European Society of Human Reproduction and Embryology (ESHRE), Society for Assisted Reproductive Technology (SART), Human Fertilisation and Embryology Authority (HFEA UK), National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Center for Biotechnology Information (NCBI/PubMed) databases including Fertility and Sterility and Human Reproduction journals, OECD Family Database, EU Eurostat Health Database, and national health ministry reports from key markets. These sources were used to collect IVF cycle statistics, regulatory approval data for fertility devices and drugs, clinical success rate studies, demographic fertility trends, patient demographic data, and market landscape analysis for in vitro fertilization, intracytoplasmic sperm injection, artificial insemination, donor egg services, and surrogacy.
Primary Research
To gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research phase. CEOs, VPs of clinical operations, directors of laboratories, and heads of regulatory affairs from networks of fertility clinics, producers of reproductive technologies, cryobanks, and fertility pharmaceutical businesses were examples of supply-side sources. Board-certified reproductive endocrinologists, male infertility-focused urologists, directors of IVF laboratories, administrators of fertility clinics, and procurement leads from home care fertility service providers, hospital reproductive medicine departments, and fertility clinics were among the demand-side sources. Primary research confirmed fertility technology pipeline timelines, validated market segmentation across treatment types and patient demographics, and collected data on patient flow analysis, insurance coverage dynamics, pricing strategies for IVF packages and fertility medications, and clinical adoption patterns.
Primary Respondent Breakdown:
By Designation: C-level Executives (28%), Director Level (35%), Others (37%)
By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)
Market Size Estimation
Global market valuation was derived through revenue mapping and procedure volume analysis across fertility treatments. The methodology included:
Identification of 50+ key fertility service providers and reproductive technology manufacturers across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa
Service mapping across in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), artificial insemination (IUI), donor egg programs, surrogacy services, fertility diagnostics, and consultation services
Analysis of reported and modeled annual revenues specific to fertility service portfolios and ART (Assisted Reproductive Technology) procedure volumes
Coverage of fertility clinics and service providers representing 70-75% of global market share in 2024
Procedure volume data collection for IVF cycles (fresh and frozen embryo transfers), ICSI procedures, intrauterine insemination cycles, egg freezing cycles, and donor services by country
Extrapolation using bottom-up (procedure volume × average selling price by treatment type and country) and top-down (fertility clinic network revenue validation) approaches to derive segment-specific valuations for female infertility, male infertility, same-sex couples, and single parent services
This methodology structure maintains the rigorous approach of your dermal filler example while adapting to the specific regulatory landscape, professional societies, and data sources unique to the fertility services sector.
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah MalgeriCo-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph AguayoSales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkampAccount and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria DoddProgram Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan ChoiSenior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile").
In general the report is well structured. Thanks very much for your efforts.”
Mark IrwinManagement Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob KooikerGroup Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif MorogluStrategy & Business Development Director
“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”
Guilherme Gomes MartinsProduct Management Director